FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:401 February 9, 1995 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: Many medications interfere with the assays for catecholamine metabolites in urine that are used to evaluate patients suspected of having a pheochromocytoma.^1,2 We report the effect of buspirone, a commonly used anxiolytic agent, on these assays.

A 49-year-old man with a four-year history of hypertension was referred for evaluation for a possible pheochromocytoma. He had a one-year history of episodic anxiety, dizziness, and palpitation that improved when he lay down. He was treated with buspirone (5 or 10 mg three times a day), with some improvement. He also had hypertension, which was treated with amlodipine (5 mg . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Karagiannis, A., Mikhailidis, D. P, Athyros, V. G, Harsoulis, F. (2007). Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14: 935-956 [Abstract] [Full Text]